{
  "claims": [
    {
      "id": 176760,
      "index": 16,
      "node_name": "claim 16",
      "node_value": "A compound of formula (I):&#10;&#10;&#10;&#10;&#10;a tautomeric form, or pharmaceutically acceptable salt thereof, wherein Ar represents a single or fused group selected from the group consisting of aryl, heterocyclyl or heteroaryl group, optionally substituted with one or more groups selected from the group consisting of hydroxy, halo, amino or optionally substituted groups selected from the group consisting of linear or branched alkyl, monosubstituted or disubstituted amino, alkoxy or acyl group wherein the substituted alkyl, monosubstituted or disubstituted amino, alkoxy or acyl group is substituted by one or more of hydroxy, halo, amino, linear or branched alkyl, monosubstituted or disubstituted amino, alkoxy or acyl group;&#10;a) A represents an optionally substituted heteroaromatic group, and X is selected from the group consisting of —CH2—, O, S, SO, SO2, or NR′, where R′ represents H or an optionally substituted group selected from linear or branched alkyl and cycloalkyl group and m and n represent integers such that 1≦m+n≦3;&#10;b) A represents a substituted aromatic group, and X is selected from the group consisting of O, S, SO, SO2, or NR′, where R′ represents H or an optionally substituted group selected from linear or branched alkyl, and cycloalkyl group and m and n represent integers such that 2≦m+n≦3; or&#10;c) A represents optionally substituted heterocyclic groups, and X is selected from the group consisting of —CH2—, O, S, SO, SO2, or NR′, where R′ represents H or an optionally substituted group selected from linear or branched alkyl and cycloalkyl groups and m and n represent integers such that 1≦m+n≦3;&#10;wherein when A is substituted, the one or more substituents are the selected from the group consisting of halogen, hydroxyl, thio, nitro, amino, cyano, or an optionally substituted group selected from linear or branched alkyl, alkoxy, thioalkyl, haloalkyl, haloalkoxy, acyl, and aminoalkyl groups; wherein the substituted alkyl, alkoxy, thioalkyl, haloalkyl, haloalkoxy, acyl and aminoalkyl groups are substituted by one or more of halogen, hydroxyl, thio, nitro, amino, cyano, linear or branched alkyl, alkoxy, thioalkyl, haloalkyl, haloalkoxy, acyl, and aminoalkyl groups;&#10;R1 represents O, S, or the group represented by N-Q, where Q represents H or substituted alkyl; or R1 represents the group represented by SO2R″, where R″ represents H, —OH, halogen or a substituted or unsubstituted group selected from alkyl, aryl, heteroaryl or heterocyclic groups; R2 is either H or (C1-C6) alkyl; R3 is NRbRc wherein Rb and Rc are the same or different and are selected from an optionally substituted group selected from alkyl, aralkyl or alkenyl or Rb and Rc together with the nitrogen atom to which they are bonded, form a saturated or unsaturated heterocyclic or heteroaromatic radical.",
      "link_degree": 1,
      "references": [
        0
      ],
      "group": 1
    },
    {
      "id": 176763,
      "index": 17,
      "node_name": "claim 17",
      "node_value": "A compound as claimed in claim 16, wherein the alkyl group is selected from a linear or branched alkyl group comprising from one to eight carbon atoms.",
      "link_degree": 1,
      "references": [
        16
      ],
      "group": 1
    },
    {
      "id": 176766,
      "index": 18,
      "node_name": "claim 18",
      "node_value": "A compound as claimed in claim 16, wherein the aryl group is selected from a monocyclic, bicyclic or tricyclic aryl group.",
      "link_degree": 1,
      "references": [
        16
      ],
      "group": 1
    },
    {
      "id": 176769,
      "index": 19,
      "node_name": "claim 19",
      "node_value": "A compound as claimed in claim 16, wherein the aryl group is selected from phenyl, naphthyl, tetrahydronaphthyl, indane, and biphenyl group.",
      "link_degree": 1,
      "references": [
        16
      ],
      "group": 1
    },
    {
      "id": 176772,
      "index": 20,
      "node_name": "claim 20",
      "node_value": "A compound as claimed in claim 16, wherein the heterocyclyl is selected from saturated, partially saturated or unsaturated aromatic or non-aromatic mono, bi or tricyclic groups, containing one or more heteroatoms selected from N, O, and S.",
      "link_degree": 1,
      "references": [
        16
      ],
      "group": 1
    },
    {
      "id": 176775,
      "index": 21,
      "node_name": "claim 21",
      "node_value": "A compound as claimed in claims 16, wherein the heterocycyl group is selected from the group consisting of aziridinyl, azetidinyl, pyrrolidinyl, imidazolidinyl, piperidinyl, piperazinyl, 2-oxopiperidinyl, 4-oxopiperidinyl, 2-oxopiperazinyl, 3-oxopiperazinyl, morpholinyl, thiomorpholinyl, 2-oxomorpholinyl, azepinyl, diazepinyl, oxapinyl, thiazepinyl, oxazolidinyl, thiazolidinyl, dihydrothiophene, dihydropyran, dihydrofuran, dihydrothiazole, benzopyranyl, benzopyranonyl, benzodihydrofuranyl, benzodihydrothienyl, pyrazolopyrimidonyl, azaquinazolinoyl, thienopyrimidonyl, quinazolonyl, pyrimidonyl, benzoxazinyl, benzoxazinonyl, benzothiazinyl, benzothiazinonyl, and thieno piperidinyl groups.",
      "link_degree": 1,
      "references": [
        16
      ],
      "group": 1
    },
    {
      "id": 176778,
      "index": 22,
      "node_name": "claim 22",
      "node_value": "A compound as claimed in claim 16, wherein the heteroaryl group is selected from optionally fused mono, bi or tricyclic aromatic heteroaromatic groups containing one or more heteroatoms selected from O, N and S.",
      "link_degree": 1,
      "references": [
        16
      ],
      "group": 1
    },
    {
      "id": 176781,
      "index": 23,
      "node_name": "claim 23",
      "node_value": "A compound as claimed in claim 16, wherein the heteroaryl group is selected from the group consisting of pyridyl, thienyl, furyl, pyrrolyl, oxazolyl, thiazolyl, isothiazolyl, imidazolyl, isoxazolyl, oxadiazolyl, thiadiazolyl, triazolyl, tetrazolyl, benzofuranyl, benzothienyl, indolinyl, indolyl, azaindolyl, azaindolinyl, pyrazolopylimidinyl, azaquinazolinyl, pyridofuranyl, pyridothienyl, thienopyrimidyl, quinolinyl, pyrimidinyl, pyrazolyl, quinazolinyl, pyridazinyl, triazinyl, benzimidazolyl, benzotriazolyl, phthalazynil, naphthylidinyl, purinyl, carbazolyl, phenothiazinyl, phenoxazinyl, benzoxazolyl, and benzothiazolyl group.",
      "link_degree": 1,
      "references": [
        16
      ],
      "group": 1
    },
    {
      "id": 176784,
      "index": 24,
      "node_name": "claim 24",
      "node_value": "A compound as claimed in claim 16, selected from the group consisting of:&#10;4-Chloro-N-{[8-chloro-1-(2,4-dichloro-phenyl)-1,4,5,6-tetrahydro-1,2-diaza-benzo[e]azulene-3-yl]-methylamino-methylene}-benzenesulfonamide and its pharmaceutically acceptable salts;&#10;8-chloro-1-(2,4-dichloro-phenyl)-4,5-dihydro-1H-6-oxa-1,2-diaza-benzo[e]azulene-3-carboxylic acid piperidin-1-ylamide and its pharmaceutically acceptable salts;&#10;8-chloro-1-(2,4-dichloro-phenyl)-4,5-dihydro-1H-6-oxa-1,2-diaza-benzo[e]azulene-3-carboxylic acid-(4-hydroxy-piperidin-1-yl-amide and its pharmaceutically acceptable salts;&#10;8-chloro-1-(2,4-dichloro-phenyl)-4,5-dihydro-1H-6-oxa-1,2-diaza-benzo[e]azulene-3-carboxylic acid pyrrolidin-1-yl amide and its pharmaceutically acceptable salts;&#10;8-chloro-1-(2,4-dichloro-phenyl)-4,5-dihydro-1H-6-oxa-1,2-diaza-benzo[e]azulene-3-carboxylic acid (hexahydro-cyclopenta[c]pyrrol-2-yl)-amide and its pharmaceutically acceptable salts;&#10;8-chloro-1-(2,4-dichloro-phenyl)-4,5-dihydro-1H-6-oxa-1,2-diaza-benzo[e]azulene-3-carboxylic acid morpholine-4-yl-amide and its pharmaceutically acceptable salts;&#10;8-chloro-1-(2,4-dichloro-phenyl)-4,5-dihydro-1H-6-oxa-1,2-diaza-benzo[e]azulene-3-carboxylic acid (4-methyl-piperazine-1-yl)-amide and its pharmaceutically acceptable salts;&#10;8-chloro-1-(4-chloro-phenyl)-4,5-dihydro-1H-6-oxa-1,2-diaza-benzo[e]azulene-3-carboxylic acid piperidin-1-ylamide and its pharmaceutically acceptable salts;&#10;8-chloro-1-(4-chloro-phenyl)-4,5-dihydro-1H-6-oxa-1,2-diaza-benzo[e]azulene-3-carboxylic acid pyrrolidin-1-ylamide and its pharmaceutically acceptable salts;&#10;8-chloro-1-(4-chloro-phenyl)-4,5-dihydro-1H-6-oxa-1,2-diaza-benzo[e]azulene-3-carboxylic acid morpholin-4-ylamide and its pharmaceutically acceptable salts;&#10;8-chloro-1-(4-chloro-phenyl)-4,5-dihydro-1H-6-oxa-1,2-diaza-benzo[e]azulene-3-carboxylic acid N′-cyclopropyl-hydrazide and its pharmaceutically acceptable salts;&#10;8-chloro-1-(4-chloro-phenyl)-4,5-dihydro-1H-6-oxa-1,2-diaza-benzo[e]azulene-3-carboxylic acid piperidin-1-ylamide and its pharmaceutically acceptable salts;&#10;1-(2,4-Dichloro-phenyl)-8-methyl-4,5-dihydro-1H-6-oxa-1,2-diaza-benzo[e]azulene-3-carboxylic acid piperidin-1-ylamide and its pharmaceutically acceptable salts;&#10;1-(2,4-Dichloro-phenyl)-8-methyl-4,5-dihydro-1H-6-oxa-1,2-diaza-benzo[e]azulene-3-carboxylic acid pyrrolidin-1-ylamide and its pharmaceutically acceptable salts;&#10;1-(4-chloro-phenyl)-8-methyl-4,5-dihydro-1H-6-oxa-1,2-diaza-benzo[e]azulene-3-carboxylic acid piperidin-1-ylamide and its pharmaceutically acceptable salts;&#10;1-{[8-chloro-1-(2,4-dichloro-phenyl)-1,4,5,6-tetrahydro-7-thia-1,2-diaza-cyclopenta [e]azulene-3-carboxylic acid piperidin-1-ylamide and its pharmaceutically acceptable salts;&#10;8-Chloro-1-(2,4-dichloro-phenyl)-1,4,5,6-tetrahydro-7-thia-1,2-diaza-cyclopenta [e]azulene-3-carboxylic acid (hexahydro-cyclopenta[c]pyrrol-2-yl)-amide and its pharmaceutically acceptable salts;&#10;8-Chloro-1-(2,4-dichloro-phenyl)-4,5-dihydro-1H-6,7-dithia-1,2-diaza-cyclopenta[e]azulene-3-carboxylic acid piperidin-1-ylamide and its pharmaceutically acceptable salts;&#10;7-Chloro-1-(2,4-dichloro-phenyl)-1,5-dihydro-4,6-dithia-1,2-diaza-as-indacene-3-carboxylic acid piperidin-1-ylamide and its pharmaceutically acceptable salts;&#10;7-Chloro-1-(2,4-dichloro-phenyl)-1,5-dihydro-4,6-dithia-1,2-diaza-as-indacene-3-carboxylic acid (hexahydro-cyclopenta [c]pyrrol-2-yl)-amide and its pharmaceutically acceptable salts;&#10;8-Chloro-1-(2,4-dichloro-phenyl)-4,5-dihydro-1H-6-thia-1,2-diaza-benzo[e]azulene-3-carboxylic acid piperidin-1-ylamide and its pharmaceutically acceptable salts; and&#10;8-Bromo-1-(2,4-dichloro-phenyl)-4,5-dihydro-1H-6-oxa-1,2-diaza-benzo[e]azulene-3-carboxylic acid piperidin-1-ylamide and its pharmaceutically acceptable salts.",
      "link_degree": 1,
      "references": [
        16
      ],
      "group": 1
    },
    {
      "id": 176787,
      "index": 25,
      "node_name": "claim 25",
      "node_value": "A pharmaceutical composition which comprises a compound as claimed in claim 16 and at least one of a pharmaceutically acceptable carrier, diluent or excipient.",
      "link_degree": 1,
      "references": [
        16
      ],
      "group": 1
    },
    {
      "id": 176790,
      "index": 26,
      "node_name": "claim 26",
      "node_value": "A pharmaceutical composition which comprises a compound as claimed in claim 24 and at least one of a pharmaceutically acceptable carrier, diluent or excipient.",
      "link_degree": 1,
      "references": [
        24
      ],
      "group": 1
    },
    {
      "id": 176793,
      "index": 27,
      "node_name": "claim 27",
      "node_value": "A method of treatment of a disease associated with cannabinoid receptors by administering a therapeutically recommended amount of the compound as claimed in claim 16 to a mammal, in need of such treatment.",
      "link_degree": 1,
      "references": [
        16
      ],
      "group": 1
    },
    {
      "id": 176796,
      "index": 28,
      "node_name": "claim 28",
      "node_value": "A method of treatment of a disease associated with cannabinoid receptors by administering a therapeutically recommended amount of the composition as claimed in claim 24 to a mammal, in need of such treatment.",
      "link_degree": 1,
      "references": [
        24
      ],
      "group": 1
    },
    {
      "id": 176799,
      "index": 29,
      "node_name": "claim 29",
      "node_value": "A method of treatment of a disease associated with cannabinoid receptors by administering a therapeutically recommended amount of the composition as claimed in claim 25 to a mammal, in need of such treatment.",
      "link_degree": 1,
      "references": [
        25
      ],
      "group": 1
    },
    {
      "id": 176802,
      "index": 30,
      "node_name": "claim 30",
      "node_value": "A method of treatment of a disease associated with cannabinoid receptors by administering a therapeutically recommended amount of the composition as claimed in claim 26 to a mammal, in need of such treatment.",
      "link_degree": 1,
      "references": [
        26
      ],
      "group": 1
    },
    {
      "id": 176805,
      "index": 31,
      "node_name": "claim 31",
      "node_value": "The method according to claim 27, wherein the mammal is a human.",
      "link_degree": 1,
      "references": [
        27
      ],
      "group": 1
    },
    {
      "id": 176808,
      "index": 32,
      "node_name": "claim 32",
      "node_value": "A process for preparing a compound of formula (I) as claimed in claim 16, wherein Ar, A, X, R1, R2, R3, m and n are as defined in claim 16, comprises the steps of:&#10;i) converting a compound of formula (2) to compound of formula (4) by reacting with a substituted hydrazine hydrochloride of formula (3),&#10;&#10;&#10;&#10;&#10;&#10;wherein A, X, m and n are as defined in claim 16 and R is an alkyl group&#10;ii) hydrolyzing the compound of formula (4) to obtain the acid of formula (5),&#10;&#10;&#10;&#10;&#10;&#10;wherein A, X, m and n are as defined in claim 16; and R is an alkyl group;&#10;iii) converting the compound of formula (5) to compound of formula (I) by treating with suitable substituted amine of formula NR2R3, where R2 and R3 are as defined in claim 16,&#10;&#10;&#10;&#10;&#10;iv) alternatively, converting the compound of formula (5) to a compound of formula (7) by treatment with a compound of formula NH2Q, where Q is as defined in claim 16,&#10;&#10;&#10;&#10;&#10;v) converting the compound of formula (7) to compound of formula (8)&#10;&#10;&#10;&#10;&#10;&#10;where Ar, A, X, Q, m and n are as defined in claim 16; and&#10;vi) converting the compound of formula (8) to a compound of formula (I) by treatment with a substituted amine of formula NR2R3, where R2 and R3 are as defined in claim 16",
      "link_degree": 1,
      "references": [
        16
      ],
      "group": 1
    },
    {
      "id": 176811,
      "index": 33,
      "node_name": "claim 33",
      "node_value": "An intermediate of formula (2)&#10;&#10;&#10;&#10;wherein:&#10;a) A represents an optionally substituted heteroaromatic group, and X is selected from the group consisting of —CH2—, O, S, SO, SO2, or NR′, where R′ represents H or a optionally substituted group selected from linear or branched alkyl and cycloalkyl groups and m and n represent integers such that 1≦m+n≦3;&#10;b) A represents a substituted aromatic group and X is selected from the group consisting of O, S, SO, SO2, or NR′, where R′ represents H or a optionally substituted group selected from linear or branched alkyl, and cycloalkyl group and m and n represents integers such that 2≦m+n≦3;&#10;c) A represents an optionally substituted heterocyclic group, and X is selected from the group consisting of —CH2—, O, S, SO, SO2, or NR, where R′ represents H or an optionally substituted group selected from linear or branched alkyl and cycloalkyl groups and m and n represents integers such that 1≦m+n≦3; or&#10;d) A represents an optionally substituted alicyclic group, and X is selected from the group consisting of —CH2—, O, S, SO, SO2, or NR′, where R′ represents H or an optionally substituted group selected from linear or branched alkyl and cycloalkyl groups and m and n represents integers such that 1≦m+n≦3; and&#10;R represents an alkyl group.",
      "link_degree": 1,
      "references": [
        0
      ],
      "group": 1
    }
  ],
  "claim_links": [
    {
      "source": 176763,
      "target": 176760,
      "value": 1
    },
    {
      "source": 176766,
      "target": 176760,
      "value": 1
    },
    {
      "source": 176769,
      "target": 176760,
      "value": 1
    },
    {
      "source": 176772,
      "target": 176760,
      "value": 1
    },
    {
      "source": 176775,
      "target": 176760,
      "value": 1
    },
    {
      "source": 176778,
      "target": 176760,
      "value": 1
    },
    {
      "source": 176781,
      "target": 176760,
      "value": 1
    },
    {
      "source": 176784,
      "target": 176760,
      "value": 1
    },
    {
      "source": 176787,
      "target": 176760,
      "value": 1
    },
    {
      "source": 176790,
      "target": 176784,
      "value": 1
    },
    {
      "source": 176793,
      "target": 176760,
      "value": 1
    },
    {
      "source": 176796,
      "target": 176784,
      "value": 1
    },
    {
      "source": 176799,
      "target": 176787,
      "value": 1
    },
    {
      "source": 176802,
      "target": 176790,
      "value": 1
    },
    {
      "source": 176805,
      "target": 176793,
      "value": 1
    },
    {
      "source": 176808,
      "target": 176760,
      "value": 1
    }
  ],
  "links": {
    "is_parentChem_of": [
      {
        "source": 176763,
        "target": 176760,
        "source_value": "compound",
        "target_value": "salt"
      },
      {
        "source": 176766,
        "target": 176760,
        "source_value": "compound",
        "target_value": "salt"
      },
      {
        "source": 176769,
        "target": 176760,
        "source_value": "compound",
        "target_value": "salt"
      },
      {
        "source": 176772,
        "target": 176760,
        "source_value": "compound",
        "target_value": "salt"
      },
      {
        "source": 176775,
        "target": 176760,
        "source_value": "compound",
        "target_value": "salt"
      },
      {
        "source": 176778,
        "target": 176760,
        "source_value": "compound",
        "target_value": "salt"
      },
      {
        "source": 176781,
        "target": 176760,
        "source_value": "compound",
        "target_value": "salt"
      },
      {
        "source": 176784,
        "target": 176760,
        "source_value": "compound",
        "target_value": "salt"
      },
      {
        "source": 176787,
        "target": 176760,
        "source_value": "compound",
        "target_value": "salt"
      },
      {
        "source": 176790,
        "target": 176760,
        "source_value": "compound",
        "target_value": "salt"
      },
      {
        "source": 176793,
        "target": 176760,
        "source_value": "compound",
        "target_value": "salt"
      },
      {
        "source": 176808,
        "target": 176760,
        "source_value": "compound",
        "target_value": "salt"
      },
      {
        "source": 176760,
        "target": 176784,
        "source_value": "compound",
        "target_value": "salts"
      },
      {
        "source": 176763,
        "target": 176784,
        "source_value": "compound",
        "target_value": "salts"
      },
      {
        "source": 176766,
        "target": 176784,
        "source_value": "compound",
        "target_value": "salts"
      },
      {
        "source": 176769,
        "target": 176784,
        "source_value": "compound",
        "target_value": "salts"
      },
      {
        "source": 176772,
        "target": 176784,
        "source_value": "compound",
        "target_value": "salts"
      },
      {
        "source": 176775,
        "target": 176784,
        "source_value": "compound",
        "target_value": "salts"
      },
      {
        "source": 176778,
        "target": 176784,
        "source_value": "compound",
        "target_value": "salts"
      },
      {
        "source": 176781,
        "target": 176784,
        "source_value": "compound",
        "target_value": "salts"
      },
      {
        "source": 176787,
        "target": 176784,
        "source_value": "compound",
        "target_value": "salts"
      },
      {
        "source": 176790,
        "target": 176784,
        "source_value": "compound",
        "target_value": "salts"
      },
      {
        "source": 176793,
        "target": 176784,
        "source_value": "compound",
        "target_value": "salts"
      },
      {
        "source": 176808,
        "target": 176784,
        "source_value": "compound",
        "target_value": "salts"
      }
    ]
  }
}